DIRS.INFO The most relevant business & tech news

☆ I became CEO of a company that has helped millions of kids read—here's my no. 1 piece of career advice
▼ + stars: | 2024-11-15 | by ( Ernestine Siu | In Ernestinesiu | ) www.cnbc.com time to read: +9 min

Courtesy of Dr. Geetha Murali. Courtesy of Dr. Geetha Murali. "The human being, if given the basics... you are capable of so much more than you really think you are. Dr. Geetha Murali in Vietnam. Courtesy of Dr. Geetha Murali.

Persons: Geetha Murali, ” Murali, CNBC's, Read, Murali, —, Murali's, , wasn't, Michelle Obama, she's Organizations: UNESCO, CNBC, Indian Army, University of California, South Asian Studies, UC Berkeley Locations: New York, East, India, U.S, biostatistics, Berkeley, Vietnam

☆ A tough week for stocks may soon force us to act. Here's where we would look to buy first
▼ + stars: | 2024-11-15 | by ( Jeff Marks | ) www.cnbc.com time to read: +6 min

Markets sink: Stocks are taking it on the chin Friday, capping off a week in which the S & P 500 fell about 2%. Bright spots : The two best-performing S & P 500 sectors this week are financials and energy. Health care was far and away the worst-performing group in the S & P 500. Next week: There's 11 companies in the S & P 500 reporting next week. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER .

Persons: Jim Cramer, There's, Donald Trump's, Jerome Powell, Trump, –, Morgan Stanley, Wells Fargo, Robert F, Kennedy Jr, Eli Lilly, we'll, Stanley Black, Decker, Jim Cramer's, Jim Organizations: CNBC, Traders, – BlackRock, Energy, Coterra Energy, Disney, Department of Health, Human Services, pharma, Nvidia, Walmart, Viking Holdings, TJX Companies, Palo Alto Networks, Target, Williams, Club, BJ's, Ross Stores, Baidu, PDD Holdings, GE Healthcare, Jim Cramer's Charitable Locations: Wells Fargo, Sonoma, Snowflake, Palo Alto

☆ Elon Musk is a showman, not an accountant
▼ + stars: | 2024-11-14 | by ( Allison Morrow | ) edition.cnn.com time to read: +6 min

The merch will be 🔥🔥🔥”If you need more evidence of how silly this whole thing is, note (as many commentators did online) that the efficiency department is being overseen by two people. On the campaign trail last month, Musk was asked how much he thought he could cut from the nation’s $6.5 trillion budget. Musk would be lucky to find $200 billion in the federal budget, former Treasury Secretary Larry Summers said at the Economic Club of New York on Tuesday. Even Trump joked to House Republicans on Wednesday that he can’t get rid of Musk, a source in the room told CNN. And that means Musk himself, as Tesla’s largest individual shareholder, is $55 billion richer today than he was a week ago.

Persons: Donald Trump, Elon Musk, ”, he’s, Vivek Ramaswamy, ” Trump, Elon, Vivek, Trump, Musk, ments on Organizations: New, New York CNN, bro, “ Department, Government, Ford, United Airlines, Republican Congress Locations: New York, le

☆ Cheat sheet: How RFK Jr., Trump's pick for HHS secretary, promises to 'Make America Healthy Again'
▼ + stars: | 2024-11-14 | by ( Hilary Brueck | ) www.businessinsider.com time to read: +9 min

Robert F. Kennedy Jr. is President-elect Trump's pick to lead the US Department of Health and Human Services. Advertisement"Make America Healthy Again" is the new healthcare slogan from Robert F. Kennedy Jr., President-elect Trump's new pick for Health and Human Services secretary. AdvertisementHere's what we know so far about Kennedy's public health philosophy, and what kinds of reforms he might fight for in 2025 and beyond. Kennedy's MAHA ideas include shifts in some basic public health protocolsMost Americans have fluoridated tap water. His stance has public health officials spooked, because part of what makes vaccination work so well is the fact that nearly everyone in our society does it.

Persons: Robert F, Kennedy Jr, Trump's, He's, he'll, —, Trump, Kennedy, Leonard Ortiz, I'm, Mandy Cohen, Lindsey Nicholson, Robert Califf, John F, Kennedy's, Bernie Sanders, it's Organizations: US Department of Health, Human Services, RFK, Service, Health, HHS, National Institutes of Health, for Disease Control, Prevention, Food and Drug Administration, MediaNews, Orange, Getty, NBC, Washington DC, Union, FDA, Pharma, Big Pharma Locations: Washington, California, Trump

☆ Lina Khan likely to be fired as FTC Chair under a Trump presidency
▼ + stars: | 2024-11-12 | by ( Allison Morrow | ) edition.cnn.com time to read: +5 min

Representatives for Trump’s transition team and the FTC didn’t respond to requests for comment. Wall Street, which has been on a tear since Trump’s decisive victory last week, appears to be ready to turn the page on the Khan era. Similarly, the FTC has gone after Big Tech, Big Pharma and even Big Mattress in the name of keeping competition robust. To them, Khan and her DOJ partner in trustbusting, Jonathan Kanter, represent a threat to the bottom line. Since last week’s election, both Kroger and Albertsons shares have risen sharply as investors anticipate the deal would face little resistance under Trump’s FTC.

Persons: CNN Business ’, New York CNN — Lina Khan’s, Donald Trump, Khan, she’s, Lina Khan, Jennifer Rie, kowtow, Jonathan Kanter, Elon Musk, Trump, ” Barry Diller, “, ‘, Republican “ Khanservative, JD Vance, Gail Slater, Vance, ”, David Kostin, Goldman Sachs, Kostin, Donald Trump’s, Brian Gardner, ” Gardner, Susie Wiles Organizations: CNN Business, New York CNN, Federal Trade Commission, FTC, Republican, Bloomberg Intelligence, CNN, Justice, Albertsons, Big Tech, Big Pharma, IAC, Democratic, Bloomberg, Kroger, Trump’s FTC, Goldman Sachs ’, White, Trump, Federal Reserve Locations: New York, it’s, trustbusting, Washington

☆ Trade Tracker: Jim Lebenthal buys more Abbvie
▼ + stars: | 2024-11-11 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailTrade Tracker: Jim Lebenthal buys more AbbvieJim Lebenthal, chief equity strategist at Cerity Partners, joins CNBC's 'Halftime Report' to discuss why he's buying more of the pharma stock on this dip.

Persons: Jim Lebenthal Organizations: Cerity Partners, pharma

☆ Caligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value
▼ + stars: | 2024-11-09 | by ( Kenneth Squire | ) www.cnbc.com time to read: +7 min

It invests in a concentrated portfolio of small and midcap life sciences companies, using activism as a tool to unlock value. A successful drug like Ohtuvayre would not just increase the life expectancies of patients with COPD, but it would lower costs for both health-care providers and COPD patients. Currently, there are over 8.6 million U.S. COPD patients with over 4 million remaining symptomatic despite treatment from the current commercial therapies. In early pooling analysis, Ohtuvayre showed a 41% reduction in exacerbations in COPD patients, almost double brensocatib. When Caligan announced its Verona position last month, the stock was trading at $33.40 per share or a $2.5 billion enterprise value.

Persons: Caligan, David Johnson, Ohtuvayre, Verona's, Verona, MorphoSys, bode, Ken Squire Organizations: Verona Pharma, Caligan Partners, Carlyle Group, FDA, MorphoSys AG, Novartis, pharma, 13D Locations: Verona, London, MorphoSys, Caligan's

☆ The sectors — and stocks — to buy in Asia after Trump's win, according to analysts
▼ + stars: | 2024-11-08 | by ( Amala Balakrishner | In Amala-Balakrishner | ) www.cnbc.com time to read: +3 min

Former U.S. President Donald Trump's victory over Vice President Kamala Harris in this week's election has raised questions about how Asia will be impacted. "When passed, the [tariffs] will sweep across Asia, particularly China [and] should spike volatility and compress multiples as uncertainty prevails." Even so, the analysts say the region is "more prepared than in 2016" and investment opportunities remain, especially given the weaker yen and stimulus in China. This will bring about "structural shifts in global supply chain ... [and] could boost infrastructure spending in ASEAN and South Asia," he added. The currency has fallen versus the dollar following Trump's win, hitting 154.7 per dollar on Wednesday — its weakest level since July 30.

Persons: Donald Trump's, Kamala Harris, India's, Hong, Tai Hui, Hui, Stocks, — CNBC's Lim Hui Jie Organizations: U.S, Trump, Macquarie Research, Nikkei, Dow Jones, Nasdaq, Morgan Asset Management, Congress, Mitsubishi Electric, Mitsubishi, Japanese pharma, Chugai Pharmaceutical, SK Hynix Locations: Asia, China, ASEAN, South Asia, U.S, Macquarie, Japan

☆ AstraZeneca shares fall on report of potential China probe fallout
▼ + stars: | 2024-11-05 | by ( ) www.cnbc.com time to read: +2 min

The Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai, China, July 7, 2021. "As a matter of policy, we do not comment on speculative media reports including those related to ongoing investigations in China," AstraZeneca said. "If requested, we will fully cooperate with the Chinese authorities," the company added and said that its operations and delivery of medicines were ongoing in China. AstraZeneca is one of the biggest multinational drugmakers in China, which accounts for 13% of its overall revenue. In 2022, Chinese authorities had summoned AstraZeneca officials over an investigation of suspected medical insurance fraud by its employees, and had ordered that the drugmaker tighten its marketing activities.

Persons: Leon Wang, Wang, AstraZeneca Organizations: Astrazeneca, Artificial Intelligence, AstraZeneca, country's pharma Locations: Shanghai, China, Swedish

☆ Trump says he will give RFK Jr. a major health role if he wins the White House. Here's what that means for patients, drugmakers
▼ + stars: | 2024-11-05 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +10 min

Some health experts said elevating Kennedy, even in an informal Trump administration position, could potentially lead to severe consequences for patients, drugmakers and the nation's public health overall. That could exacerbate the nation's existing public health challenges, such as declining childhood vaccination rates for several preventable diseases, some experts say. "I think we could reasonably predict that there would be a decline in vaccination rates among children, and perhaps vaccination overall." Drugmakers such as Pfizer and Moderna are still recovering from falling Covid vaccination rates in the U.S., which have dented their profits over the last two years. Kennedy's other proposals for overhauling federal health agencies will likely be difficult to execute.

Persons: Donald Trump, Robert F, Kennedy Jr, Anna Moneymaker, Kennedy, Trump, Dr, Paul Offit, Drew Altman, Altman, Genevieve Kanter, Cynthia Blancas, Deep Patel, Christina House, they've, Offit, Andrew Kelly, USC's Kanter, that's, Georges Benjamin, Covid, Kanter Organizations: Gas, Getty, White House, Trump, Children's Hospital of Philadelphia, CNBC, and Drug Administration, Centers for Disease Control, Commonwealth Fund, Senate, Washington Post, University of Southern, CVS, Los Angeles Times, CDC, Pfizer, Moderna, NBC, Health Defense, FDA, Department of Health, Human Services, U.S . Food, Drug Administration, Reuters, American Public Health Association, Pharma Locations: Duluth , Georgia, U.S, University of Southern California, Lynwood, Huntington Park, Samoa, White Oak , Maryland

☆ Tariffs could have trickle-down effects across global pharmaceutical industry, says CEO
▼ + stars: | 2024-11-04 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailTariffs could have trickle-down effects across global pharmaceutical industry, says CEOJohn Graham, Group CEO of Zuellig Pharma, talks about election risks, US-China tensions, and how tariffs and protectionism could affect the pharmaceutical industry.

Persons: John Graham Organizations: Zuellig Pharma Locations: China

In Wisconsin’s hotly contested U.S. Senate race, Republican Eric Hovde has focused much of his closing messaging on attacking the finance career of Democratic Sen. Tammy Baldwin’s girlfriend, highlighting their same-sex relationship. Another Hovde campaign ad features a narrator talking about Baldwin’s relationship with Brisbane. “This is Sen. Tammy Baldwin,” the narrator says. Now vying for a third Senate term, Baldwin has said the attacks are designed to distract from her record. Baldwin campaign officials and LGBTQ rights organizations said that Hovde’s attack lines amount to a cynical ploy by Republicans.

Persons: Republican Eric Hovde, Democratic Sen, Tammy Baldwin’s, Maria Brisbane, ”, ” Baldwin, Baldwin, ” “ Tammy, Sen, Tammy Baldwin, Tammy doesn’t, Morgan Stanley, MSNBC’s “ Andrea Mitchell, Eric Hovde, Hovde, “, “ Eric Hovde, —, Zach Bannon, “ Sen, Sarah Kate Ellis, ” Kelley Robinson, ” Robinson, GLAAD didn’t, Andrew Mamo, ” “, Donald Trump Organizations: U.S, Senate, Republican, Democratic, Wall Street, Maria’s, Republicans ’, Baldwin TV, U.S . Senate, Big Pharma, ”, CNN, Banking, Human Rights, GLAAD Locations: Brisbane, Wisconsin, New York City , Wisconsin, New York, California

☆ Novartis CEO on the impact of the U.S. election for pharma
▼ + stars: | 2024-10-29 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailNovartis CEO on the impact of the U.S. election for pharmaNovartis CEO Vas Narasimhan talks to CNBC about the company's latest results and the potential impact of the U.S. election on the business.

Persons: Vas Narasimhan Organizations: Novartis, pharma Novartis, CNBC

☆ How activist Starboard may help boost value in Kenvue's skin and beauty business
▼ + stars: | 2024-10-26 | by ( Kenneth Squire | ) www.cnbc.com time to read: +8 min

The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Self Care product categories include pain care; cough cold allergy; and "other self care." The Skin Health and Beauty segment's product categories include face and body care and hair, sun and others. Skin Health and Beauty has been proven to be a marketing business whose growth can be greatly aided by social media. Kenvue has a solid business with iconic brands and one underperforming segment in Skin Health and Beauty.

Persons: Russell, Johnson, Kenvue, Michael CeraVe, Ken Squire Organizations: Skin, Health, Self, pharma, Colgate, Palmolive, Haleon, Kenvue, Essential Health, L'Oreal, Beauty, Skin Health, Management, 13D Locations: North America, Asia, Europe, Middle East, Africa, America, CY19, CeraVe

☆ What activist hedge fund Starboard wants from Pfizer
▼ + stars: | 2024-10-22 | by ( Alex Nicoll | Kaja Whitehouse | ) www.businessinsider.com time to read: +3 min

Activist hedge fund Starboard has taken a stake in drug giant Pfizer. AdvertisementActivist hedge fund manager Jeff Smith outlined his concerns about drugmaker Pfizer on Tuesday but stopped short of offering a solution — saying that's a job for the board of directors. He also shared a version of the presentation his hedge fund Starboard presented to Pfizer officials at a meeting last week. "We all get measured by our track record," Smith told the crowd. The track record is not great during this period of time in the pharma industry."

Persons: execs, —, Jeff Smith, Smith, Pfizer, It's, I'm Organizations: Pfizer, Service, 13D, pharma Locations: Manhattan, Central, Olive Garden

☆ CNBC Pro Talks: China portfolio manager reveals what he's buying right now
▼ + stars: | 2024-10-22 | by ( Cnbc.Com Staff | ) www.cnbc.com time to read: +2 min

As investors ponder how — and where — to invest in China, CNBC's Tanvir Gill will quiz China portfolio manager Jason Hsu on where he sees opportunities in the current market. Hsu previously told CNBC Pro that he was betting on tech — and artificial intelligence in particular — for the long term. Hsu set up Ranmore Fund Management in 2016, prior to which he was co-founder and vice chairman of quantitative asset manager Research Affiliates. Join CNBC Pro Talks on Wednesday, Oct. 23 at 6:30 a.m. BST / 1:30 p.m. SGT / 1:30 a.m. Learn more from our previous Pro Talks: How to play AI in a cheaper way without owning stocks like Nvidia, according to fund manager Fund manager reveals his worst trade of the year — and the lessons he learned Beyond Novo: Fund manager likes this under-the-radar pharma stock Related coverage from Pro: Is it time to invest in China?

Persons: Finance Lan Fo'an, CNBC's Tanvir Gill, Jason Hsu, Hsu, Goldman, Tanvir Gill Organizations: Finance, China's CSI, Rayliant Global Advisors, China Equity, CNBC Pro, China Equity ETF, Ping An Insurance, Midea, Ranmore Fund Management, Research, Anderson School of Management, UCLA, Nvidia, pharma, Wall, Citi Locations: China

☆ TikTok once planned to use content posted by its users to influence Mitch McConnell, lawsuit reveals
▼ + stars: | 2024-10-20 | by ( Kenneth Niemeyer | ) www.businessinsider.com time to read: +3 min

Attorneys general from 14 states are suing TikTok over claims it harms children's mental health. One document shows how the company planned to influence Sen. Mitch McConnell. Now, internal TikTok documents included in the state lawsuits are shedding new light on how TikTok tried to influence Congress during its debate on a potential ban. One of those documents revealed that TikTok planned to use content from its users to sway lawmakers, including influential Sen. Mitch McConnell, who supported the TikTok ban. Advertisement"As is standard practice at other companies, we also monitor public sentiment on issues that relate to the company," TikTok said.

Persons: TikTok, Sen, Mitch McConnell, —, McConnell Organizations: TikTok, Service, Purdue Pharma, Congress, United States, Lawmakers, Kentucky Public Radio, NPR, Kentucky Public Locations: United, Kentucky

☆ In the competitive world of pharma, companies need to focus on worker well-being to retain top talent, says Ferring's HR exec
▼ + stars: | 2024-10-15 | by ( Julia Hood | ) www.businessinsider.com time to read: +7 min

She said that Ferring has grown more intentional about focusing on worker well-being, which is particularly important for the highly competitive field of healthcare. What are the benefits for companies focused on worker well-being? We've defined well-being in a holistic way, so it's not just about physical well-being; it's also about mental well-being and financial well-being. What advice do you have for other companies that are just getting started thinking about DEI and worker well-being initiatives? What policies demonstrate your focus on worker well-being?

Persons: —, Johnson, JP Morgan, Ferring, We've, it's, I've, we've, you've Organizations: Ferring Pharmaceuticals, Service, gastroenterology, Johnson, American Express, Pharma, pharma Locations: Swiss, Switzerland

☆ Here are Monday's biggest analyst calls: Nvidia, Broadcom, Apple, Tesla, Flutter, Caterpillar, Alphabet & more
▼ + stars: | 2024-10-14 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Here are the biggest calls on Wall Street on Monday: TD Cowen reiterates Nvidia as buy TD said Nvidia remains a top pick at the firm. Goldman Sachs upgrades Ibotta to buy from neutral Goldman Sachs reiterates Alphabet as buy Goldman lowered its price target on the stock to $208 per share from $217 citing a slew of headwinds for Alphabet. Wells Fargo upgrades Flutter to overweight from equal weight Wells says investors should buy the dip in shares of the gambling company. Goldman Sachs downgrades AutoZone to sell from buy Goldman downgraded the auto parts retailer due to "muted growth." Goldman Sachs upgrades Ibotta to buy from neutral Goldman says it likes the growth opportunity for the mobile tech company.

Persons: TD Cowen, Mizuho, Goldman Sachs, Goldman, Wells, Truist, Morgan Stanley, Caterpillar, Piper Sandler, Tesla, Piper, wouldn't, it's, Baird, KeyCorp, Jefferies, it's bullish, Stock, GOOS, AppLovin, Oppenheimer Organizations: Nvidia, NVIDIA, Away Tech, Mizuho, AMD, Broadcom, UBS, Partners, Surgery Partners, Apple, VF Corp, Vans, UW, Walmart Locations: Wells Fargo, China

☆ Jefferies says buy this little-known injectable drug delivery maker with more than 30% upside
▼ + stars: | 2024-10-14 | by ( Samantha Subin | ) www.cnbc.com time to read: +1 min

It's time to buy shares of this under-the-radar injectable delivery and beauty packaging maker with more than 30% upside potential, according to Jefferies. Analyst Daniel Rizzo upgraded shares of Aptargroup to a buy rating, saying that new pharmaceutical delivery products should drive 10% sales growth on a compound annual basis through 2027. Along with the upgrade, Rizzo boosted his price target by 39% to $215 a share, representing 33% upside from Friday's close. The firm also forecasts that the company can drive 7% to 11% pharmaceuticals sales growth over the next 10 years, given that 80% of its delivery systems are protected by intellectual property tools such as patents. "The stock is up ~30% YTD ... but as new products help earnings accelerate, we expect multiple expansion to help support another ~30% increase."

Persons: Daniel Rizzo, Rizzo Organizations: Jefferies, OTC Narcan, pharma Locations: Aptargroup, U.S

☆ New lawsuits against TikTok mirror those against Big Tobacco and Purdue Pharma
▼ + stars: | 2024-10-14 | by ( Kenneth Niemeyer | ) www.businessinsider.com time to read: +5 min

Attorneys general in 14 different states filed lawsuits against TikTok last week. The suits mirror earlier ones against Big Tobacco and Purdue Pharma, legal experts told BI. The Sackler family, owners of Purdue Pharma, ultimately paid over $3 billion in settlements for misleading advertising related to their products. Purdue Pharma later filed for bankruptcy, but the Supreme Court struck down a $7 billion bankruptcy plan in June that would have given the Sackler's immunity from future civil suits. With the prospect of that federal ban looming next year, a slew of federal lawsuits helps shape public opinion and "pressure lawmakers to act," Rahmani said.

Persons: —, Adam Wandt, John Jay, Wandt, It's, wouldn't, Rahmani, Sackler, TikTok Organizations: TikTok, Big Tobacco, Purdue Pharma, Service, John, John Jay School of Criminal, Big Tech, Meta, Google, NPR Locations: California, United States

☆ Zealand Pharma seeks partner for its 'next generation' weight loss drug
▼ + stars: | 2024-10-11 | by ( Karen Gilchrist | ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailZealand Pharma seeks partner for its 'next generation' weight loss drugCNBC's Karen Gilchrist weighs in on Zealand Pharma's "next generation" obesity drug candidate and its search for a global partner.

Persons: Karen Gilchrist Organizations: Zealand Pharma

☆ Novo and Eli contender Zealand Pharma heralds its obesity drug alternative: It's our 'crown jewel'
▼ + stars: | 2024-10-11 | by ( Karen Gilchrist | ) www.cnbc.com time to read: +4 min

Jaap Arriens | NurPhotoDanish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market dominated by heavyweights Novo Nordisk and Eli Lilly . Last month, Zealand Pharma announced positive top-line results from a phase 1b trial of its weight-loss drug, a GLP-1/GLP-2 receptor dual agonist called Dapiglutide. Stock Chart Icon Stock chart icon Zealand Pharma. Novo Nordisk is also experimenting with its own version of the treatment, combining the GLP-1 component Semaglutide with amylin analog Cagrilintide in a candidate called CagriSema. Syringes from weight loss drugs "Wegovy," "Ozempic" and "Mounjaro."

Persons: Jaap Arriens, Eli Lilly, Adam Steensberg, Steensberg Organizations: Zealand Pharma, Novo Nordisk, CNBC, pharma, Nordisk, Union, Getty Locations: U.S

☆ Here are Friday's biggest analyst calls: Nvidia, Tesla, Ferrari, Meta, Amazon, Eli Lilly, Walmart, Uber & more
▼ + stars: | 2024-10-11 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Goldman Sachs reiterates Nvidia as buy Goldman raised its price target to $150 per share from $135 following a series of Nvidia management meetings. Morgan Stanley names Atlassian a top pick Morgan Stanley named Atlassian a top idea and says the software company is well positioned for share gains. Morgan Stanley reiterates Eli Lilly as overweight Morgan Stanley raised its price target on the stock to $1,158 per share from $1,106. JPMorgan reiterates Amazon, Uber and Meta as top picks JPMorgan said in a note on Friday that Amazon, Uber and Meta were the firm's top three picks heading into earnings. JPMorgan upgrades Ferrari to overweight from neutral The firm says it's more constructive on the luxury automaker following a series of management meetings.

Persons: Wells, Redburn, Mercado, Morgan Stanley downgrades Qorvo, Morgan Stanley, Goldman Sachs, Goldman, Jensen Huang, Colette Kress, Stewart Stecker, Atlassian, Eli Lilly, LLY, Mizuho downgrades Mobileye, Kinder Morgan, it's bullish, Benedetto Vigna, Investor Relations Aldo Benetti, Tesla, Guggenheim Organizations: Bank of America, Broadcom, TAM, UBS, Devices, Mercado Libre, Nvidia, Pharma, Mizuho, JPMorgan, Meta, of America, Ferrari, Investor Relations, Netflix, Guggenheim, Walmart Locations: America, OW, China

☆ Zealand Pharma targeting 'next generation' of obesity drugs, CEO says
▼ + stars: | 2024-10-11 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailZealand Pharma targeting 'next generation' of obesity drugs, CEO saysZealand Pharma's CEO Adam Steensberg weighs in on early-stage trials of its obesity drug contender and talks down takeover speculation.

Persons: Adam Steensberg Organizations: Zealand Pharma

Search resuls for: "pharma"

25 mentions found